Treatment of Advanced or Recurrent Endometrial Carcinoma with Doxorubicin in Patients Progressing after Paclitaxel/Carboplatin: Memorial Sloan-Kettering Cancer Center (MSKCC) Exper...

Por Makker, Vicky, Hensley, Martee L., Zhou, Qin, Iasonos, Alexia, Aghajanian, Carol. A.
Publicado em 2013

Radiation therapy for epithelial ovarian cancer brain metastases: clinical outcomes and predictors of survival

Por Teckie, Sewit, Makker, Vicky, Tabar, Viviane, Alektiar, Kaled, Aghajanian, Carol, Hensley, Martee, Beal, Kathryn
Publicado em 2013

Gemcitabine for Advanced Endometrial Cancer: A Review of the MSKCC Experience

Por Grisham, Rachel Nicole, Adaniel, Christina, Hyman, David, Ma, Weining, Iasonos, Alexia, Aghajanian, Carol, Konner, Jason
Publicado em 2012

Final overall survival and safety analysis of OCEANS, a phase 3 trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent ovarian cancer

Por Aghajanian, Carol, Goff, Barbara, Nycum, Lawrence R., Wang, Yan V., Husain, Amreen, Blank, Stephanie V.
Publicado no Gynecol Oncol (2015)

A Systematic Review of Ovarian Cancer and Fear of Recurrence

Por Ozga, Melissa, Aghajanian, Carol, Myers-Virtue, Shannon, McDonnell, Glynnis, Jhanwar, Sabrina, Hichenberg, Shira, Sulimanoff, Isabel
Publicado no Palliat Support Care (2015)

Treatment of Advanced Uterine Leiomyosarcoma with Aromatase Inhibitors

Por O’Cearbhaill, Roisin, Zhou, Qin, Iasonos, Alexia, Soslow, Robert A., Leitao, Mario. M., Aghajanian, Carol, Hensley, Martee L.
Publicado no Gynecol Oncol (2009)

Identifying Clinical Improvement in Consolidation Single-arm Phase II Trials in Ovarian Cancer Patients in Second or Greater Clinical Remission

Por Iasonos, Alexia, Sabbatini, Paul, Spriggs, David R., Aghajanian, Carol A., O’Cearbhaill, Roisin E., Hensley, Martee L., Thaler, Howard T.
Publicado em 2012

A retrospective assessment of outcomes of chemotherapy-based versus radiation-only adjuvant treatment for completely resected stage I–IV uterine carcinosarcoma

Por Makker, Vicky, Abu-Rustum, Nadeem R., Alektiar, Kaled M., Aghajanian, Carol. A., Zhou, Qin, Iasonos, Alexia, Hensley, Martee. L.
Publicado em 2008

Bevacizumab shows activity in patients with low-grade serous ovarian and primary peritoneal cancer

Por Grisham, Rachel N., Iyer, Gopa, Sala, Evis, Zhou, Qin, Iasonos, Alexia, DeLair, Deborah, Hyman, David M., Aghajanian, Carol
Publicado no Int J Gynecol Cancer (2014)

Ovarian Clear Cell Carcinoma, Outcomes by Stage: The MSK Experience

Por Shu, Catherine A., Zhou, Qin, Jotwani, Anjali R., Iasonos, Alexia, Leitao, Mario M., Konner, Jason A., Aghajanian, Carol A.
Publicado no Gynecol Oncol (2015)

Duration of Second or Greater Complete Clinical Remission In Ovarian Cancer: Exploring Potential Endpoints for Clinical Trials

Por Harrison, Michelle L, Gore, Martin E, Spriggs, David, Kaye, Stan, Iasonos, Alexia, Hensley, Martee, Aghajanian, Carol, Venkatraman, Ennapadam, Sabbatini, Paul
Publicado em 2007

Concurrent Carboplatin/Paclitaxel and Intravaginal Radiation in Surgical Stage I-II Serous Endometrial Cancer

Por Alektiar, Kaled M., Makker, Vicky, Abu-Rustum, Nadeem R., Soslow, Robert A., Chi, Dennis S., Barakat, Richard R., Aghajanian, Carol A.
Publicado em 2008

Consolidation Strategies in Ovarian Cancer: Observations for Future Clinical Trials

Por Sabbatini, Paul, Spriggs, David, Aghajanian, Carol, Hensley, Martee, Tew, William, Konner, Jason, Bell-McGuinn, Kathryn, Juretzka, Margrit, Iasonos, Alexia
Publicado em 2010

The Role of Systemic Chemotherapy in the Management of Granulosa Cell Tumors

Por Meisel, Jane L., Hyman, David, Jotwani, Anjali, Zhou, Qin, Abu-Rustum, Nadeem R., Iasonos, Alexia, Pike, Malcolm C., Aghajanian, Carol
Publicado no Gynecol Oncol (2014)

Phase II Evaluation of Dalantercept, a Soluble Recombinant Activin Receptor-Like Kinase 1 (ALK1) Receptor Fusion Protein, for the Treatment of Recurrent or Persistent Endometrial C...

Por Makker, Vicky, Filiaci, Virginia L., Chen, Lee-may, Darus, Christopher J., Kendrick, James E., Sutton, Gregory, Moxley, Katherine, Aghajanian, Carol
Publicado no Gynecol Oncol (2015)

Eribulin mesylate (halichondrin B Analog E7389) in platinum-resistant and platinum-sensitive ovarian cancer: a two-cohort, phase II study

Por Hensley, Martee L., Kravetz, Sara, Jia, Xiaoyu, Iasonos, Alexia, Tew, William, Pereira, Lauren, Sabbatini, Paul, Whalen, Christin, Aghajanian, Carol A., Zarwan, Corinne, Berlin, Suzanne
Publicado em 2011

OCEANS: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Chemotherapy With or Without Bevacizumab in Patients With Platinum-Sensitive Recurrent Epithelial Ovarian,...

Por Aghajanian, Carol, Blank, Stephanie V., Goff, Barbara A., Judson, Patricia L., Teneriello, Michael G., Husain, Amreen, Sovak, Mika A., Yi, Jing, Nycum, Lawrence R.
Publicado em 2012

Impact of Prophylactic Conversion to an Extended Infusion Schedule to Prevent Hypersensitivity Reactions in Ovarian Cancer Patients during Carboplatin Retreatment

Por O’Cearbhaill, Roisin, Zhou, Qin, Iasonos, Alexia, Hensley, Martee L., Tew, William P., Aghajanian, Carol, Spriggs, David R., Lichtman, Stuart M., Sabbatini, Paul J.
Publicado no Gynecol Oncol (2009)

A phase II, single arm study of iniparib in patients with BRCA1 or BRCA2 associated advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer

Por Bell-McGuinn, Katherine M., Konner, Jason A., Tew, William P., Hensley, Martee L., Iasonos, Alexia, Charpentier, Eric, Mironov, Svetlana, Sabbatini, Paul, Aghajanian, Carol
Publicado no Int J Gynecol Cancer (2016)

Phase II Trial of Bevacizumab in Recurrent or Persistent Endometrial Cancer: A Gynecologic Oncology Group Study

Por Aghajanian, Carol, Sill, Michael W., Darcy, Kathleen M., Greer, Benjamin, McMeekin, D. Scott, Rose, Peter G., Rotmensch, Jacob, Barnes, Mack N., Hanjani, Parviz, Leslie, Kimberly K.
Publicado em 2011